Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Clinical trial NCT01397786 · COMPLETED
Trial details
- NCT number
- NCT01397786
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2016-01-01
- Enrollment
- 1044
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.